Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rheumatology Research Alliance (RRA) is a specialized clinical research organization and site network focused exclusively on rheumatology and autoimmune diseases. The company partners with pharmaceutical sponsors and contract research organizations to conduct Phase 2 through Phase 4 clinical trials across a network of high-performing rheumatology practices. By integrating clinical research into private practice settings, RRA provides sponsors with access to well-characterized patient populations and experienced investigators. Their services include site selection, patient recruitment, and trial management, aimed at accelerating the development of new therapies for conditions such as rheumatoid arthritis and lupus.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rheumatology Research Alliance.